Ryan Breslow has had a tumultuous 2022. It’s not slowing him down. Few outside of Breslow’s world even knew his name a year ago. Then Bolt, a “one-click” checkout tech […]
Pharma
Trending topics and news from the Pharma category
Back to news homeSwipeRx lands $27M from MDI and Gates Foundation to digitize the pharma industry in Southeast Asia
SwipeRx, a platform for pharma professionals, said Tuesday it has secured a $27 million Series B round led by Indonesia’s MDI Ventures, with participation from the Gates Foundation, Johnson & […]
Reduced risk of CV morbidity and mortality demonstrated in FIGARO-DKD study
At this year’s European Society of Cardiology (ESC) Congress, positive results were presented from Bayer’s FIGARO-DKD Phase III trial of Kerendia (finerenone), providing insight into the drug’s ability to reduce […]
Low level of innovation and generic competition to result in the neuroendocrine tumor market growing only 0.9% by 2030, says GlobalData
The market for neuroendocrine tumors (NETs) – a rare type of tumor where cancerous growth can begin in any cell within the hormone or nervous system – is expected to […]
Despite bumetanide failure, promise remains in autism market, says GlobalData
Servier and Neurochlore have recently announced that, following a lack of efficacy in two Phase III trials of bumetanide for autism spectrum disorder (ASD) in adolescents, they would be terminating […]
Key players in psoriasis offer strong support through branded digital channels to Australian patients, says GlobalData
The psoriasis (PsO) therapeutics market in Australia is dominated by biologics such as anti-TNF, anti-IL-17, anti-IL-23, and anti-IL-12/anti-IL-23 therapies. Among these, stiff competition exists among AbbVie’s Skyrizi, Novartis’ Cosentyx, Eli […]
Diagnosed incident cases of neuroendocrine tumors in 8MM set to surpass 133,000 in 2030
The burden of diagnosed neuroendocrine tumors (NETs) is expected to increase at an annual growth rate (AGR) of 2.37% from an estimated 108,000 cases in 2020 to 133,000 in 2030 […]
Severe sepsis diagnosed incident cases set to reach 2.8 million in 2030, says GlobalData
The burden of diagnosed incident cases of severe sepsis is expected to increase at an annual growth rate (AGR) of 2%, from around 2.3 million cases in 2020 to 2.8 […]
Smart insulin pen innovations to drive the insulin delivery market to $26.8bn by 2030, says GlobalData
People with diabetes that do not have access to an insulin pump – or simply do not wish to use one – now have greater choice due to the emergence […]
ADA 2021: Eli Lilly and Novo Nordisk will continue to compete over GLP-1RA market, says GlobalData
Eli Lilly and Novo Nordisk will continue to compete over the glucagon-like peptide 1 receptor agonist (GLP-1RA) market, with the strong possibility that the two pharmaceutical giants will completely own […]